CLINIGEN GROUP PLC – Trademark Portfolio
Entity Type: 99
CLINIGEN GROUP PLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include ETHYOL, TOTECT, and CLINIGEN. The owner is based in STAFFORDSHIRE.
PITCAIRN HOUSE CROWN SQUARE
CENTRUM 100, BURTON ON TRENT
STAFFORDSHIRE DE14 2WW , GB
Showing of trademarks Trademarks
Trademark Classifications
CLINIGEN GROUP PLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does CLINIGEN GROUP PLC have?
CLINIGEN GROUP PLC has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 cancelled.
What trademark classes does CLINIGEN GROUP PLC file in?
CLINIGEN GROUP PLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CLINIGEN GROUP PLC's most well-known trademarks?
CLINIGEN GROUP PLC's registered trademark portfolio includes well-known marks such as ETHYOL, TOTECT, and CLINIGEN. These are among 5 currently registered trademarks in the portfolio.
What is CLINIGEN GROUP PLC's trademark registration success rate?
CLINIGEN GROUP PLC has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.